Top compounds associated with response to CT47A1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.019 0.6
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.021 0.6
mRNA AT13387 CTRPv2 pan-cancer AAC -0.026 0.6
mRNA FSC231 CTRPv2 pan-cancer AAC -0.04 0.6
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.018 0.6
mRNA hyperforin CTRPv2 pan-cancer AAC 0.022 0.6
Download CSV